Life Chemicals and Variational AI have launched their groundbreaking collaboration marrying best-in-class chemistry and synthesis capabilities with state-of-the-art generative AI for drug discovery. This partnership combines Life Chemicals comprehensive chemistry capabilities with Variational AI’s Enki™ Lead Generator platform, efficiently delivering generative AI-driven de novo compound generation for your hit/lead generation projects. Notably, our Custom Synthesis Services provide further advantages, streamlining your entire compound design workflow.
Enhancing Drug Discovery with Enki™ Lead Generator
Enki™ Lead Generator generates de novo compounds for your discovery program needs and is trusted by leading biopharmaceutical companies for early-stage drug discovery. For more information see https://variational.ai/
- Novel & Diverse Leads: Fast generation of unique, lead-like compounds targeting 300+ specific kinases and GPCRs.
- Extensive Data: Trained on 400M+ experimental and computational data points across hundreds of kinases and GPCRs.
- High Predictive Accuracy: Potency predictions on par with advanced free energy methods.
- Optimized for Synthesis: All compounds can be synthesized in-house by Life Chemicals, ensuring high purity and fast delivery.
Enjoy the combined expertise of Life Chemicals and Variational AI to accelerate your research. Contact us at marketing@lifechemicals.com and discover how we can boost your drug discovery with our AI-Powered Novel Lead Generation Strategies.